Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 101

1.

Diffusion-weighted MRI and 18F-FDG PET correlation with immunity in early radiotherapy response in BNL hepatocellular carcinoma mouse model: timeline validation.

Chung YH, Yu CF, Chiu SC, Chiu H, Hsu ST, Wu CR, Yang CL, Hong JH, Yen TC, Chen FH.

Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1733-1744. doi: 10.1007/s00259-019-04318-3. Epub 2019 May 24.

PMID:
31127350
2.

Distinct Tumor Microenvironment at Tumor Edge as a Result of Astrocyte Activation Is Associated With Therapeutic Resistance for Brain Tumor.

Lin CM, Yu CF, Huang HY, Chen FH, Hong JH, Chiang CS.

Front Oncol. 2019 Apr 26;9:307. doi: 10.3389/fonc.2019.00307. eCollection 2019.

3.

A Comprehensive Review on Current Advances in Peptide Drug Development and Design.

Lee AC, Harris JL, Khanna KK, Hong JH.

Int J Mol Sci. 2019 May 14;20(10). pii: E2383. doi: 10.3390/ijms20102383. Review.

4.

Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.

Hsieh CE, Venkatesulu BP, Lee CH, Hung SP, Wong PF, Aithala SP, Kim BK, Rao A, Tung-Chieh Chang J, Tsang NM, Wang CC, Lee CC, Lin CC, Tseng JH, Chou WC, Wang YC, Krishnan S, Hong JH.

Int J Radiat Oncol Biol Phys. 2019 Feb 21. pii: S0360-3016(19)30264-0. doi: 10.1016/j.ijrobp.2019.02.032. [Epub ahead of print]

PMID:
30797890
5.

Optimal Timing for Postsurgical Adjuvant Therapy in Patients with Gastric Cancer: A Propensity Score Matching Study.

Huang SM, Chen YC, Chen WY, Yang LY, Tsan DL, Tsang NM, Yap WK, Tsai CS, Leung WM, Hong JH, Chang JT, Yeh TS, Wu TH, Chen YC, Lin YH, Huang BS.

J Cancer. 2019 Jan 1;10(2):332-340. doi: 10.7150/jca.27753. eCollection 2019.

6.

Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma.

Lee AC, Shih YY, Zhou F, Chao TC, Lee H, Liao YF, Hsu WM, Hong JH.

J Mol Med (Berl). 2019 Mar;97(3):325-339. doi: 10.1007/s00109-018-1730-x. Epub 2019 Jan 5.

PMID:
30612140
7.

Metabolic Volumetric Parameters in 11C-Choline PET/MR Are Superior PET Imaging Biomarkers for Primary High-Risk Prostate Cancer.

Tseng JR, Yang LY, Lin YC, Liu CY, Pang ST, Hong JH, Yen TC, Wang LJ.

Contrast Media Mol Imaging. 2018 Nov 5;2018:8945130. doi: 10.1155/2018/8945130. eCollection 2018.

8.

New Digital Plug and Imaging Sensor for a Proton Therapy Monitoring System Based on Positron Emission Tomography.

D'Ascenzo N, Gao M, Antonecchia E, Gnudi P, Chen HH, Chen FH, Hong JH, Hsiao IT, Yen TC, Wang W, Xi D, Zhang B, Xie Q.

Sensors (Basel). 2018 Sep 8;18(9). pii: E3006. doi: 10.3390/s18093006.

9.

How small is TOO small? New liver constraint is needed- Proton therapy of hepatocellular carcinoma patients with small normal liver.

Lee CH, Hung SP, Hong JH, Chang JT, Tsang NM, Chan KM, Tseng JH, Huang SC, Lin SM, Lien JM, Liu NJ, Lin CC, Chen WT, Chen WY, Chen PJ, Huang BS.

PLoS One. 2018 Sep 11;13(9):e0203854. doi: 10.1371/journal.pone.0203854. eCollection 2018.

10.

Outcomes for Cervical Cancer Patients Treated With Radiation in High-Volume and Low-Volume Hospitals.

Lin SM, Ku HY, Chang TC, Liu TW, Chang CS, Hong JH.

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):184-193. doi: 10.1016/j.ijrobp.2018.05.038. Epub 2018 May 24.

11.

Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.

Lin G, Yang LY, Lin YC, Huang YT, Liu FY, Wang CC, Lu HY, Chiang HJ, Chen YR, Wu RC, Ng KK, Hong JH, Yen TC, Lai CH.

Eur Radiol. 2019 Feb;29(2):556-565. doi: 10.1007/s00330-018-5651-4. Epub 2018 Jul 26.

PMID:
30051142
12.

Prostate-selective α antagonists increase fracture risk in prostate cancer patients with and without a history of androgen deprivation therapy: a nationwide population-based study.

Kao WH, Kuo CF, Chou IJ, See LC, Huang WK, Chiou MJ, Zhang W, Doherty M, Wang CC, Hsu JT, Chen HH, Hong JH.

Oncotarget. 2018 Jan 2;9(4):5263-5273. doi: 10.18632/oncotarget.23828. eCollection 2018 Jan 12.

13.

Developing and validating a multivariable prediction model to improve the diagnostic accuracy in determination of cervical versus endometrial origin of uterine adenocarcinomas: A prospective MR study combining diffusion-weighted imaging and spectroscopy.

Lin G, Lin YC, Wu RC, Yang LY, Lu HY, Tsai SY, Huang YT, Huang YL, Lu KY, Ng KK, Yen TC, Chao A, Lai CH, Hong JH.

J Magn Reson Imaging. 2018 Jun;47(6):1654-1666. doi: 10.1002/jmri.25899. Epub 2017 Nov 27.

PMID:
29178414
14.

Radiosensitization of ultrasmall GNP-PEG-cRGDfK in ALTS1C1 exposed to therapeutic protons and kilovoltage and megavoltage photons.

Enferadi M, Fu SY, Hong JH, Tung CJ, Chao TC, Wey SP, Chiu CH, Wang CC, Sadeghi M.

Int J Radiat Biol. 2018 Feb;94(2):124-136. doi: 10.1080/09553002.2018.1407462. Epub 2018 Jan 8.

PMID:
29172866
15.

The prognostic impact of overall treatment time on disease outcome in uterine cervical cancer patients treated primarily with concomitant chemoradiotherapy: a nationwide Taiwanese cohort study.

Lin SM, Ku HY, Chang TC, Liu TW, Hong JH.

Oncotarget. 2017 Jul 27;8(49):85203-85213. doi: 10.18632/oncotarget.19617. eCollection 2017 Oct 17.

16.

Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.

Surveillance group; Diagnosis group; Staging group; Surgery group; Local ablation group; TACE/TARE/HAI group; Target therapy/systemic therapy group; Radiotherapy group; Prevention group; Drafting group.

J Formos Med Assoc. 2018 May;117(5):381-403. doi: 10.1016/j.jfma.2017.09.007. Epub 2017 Oct 24.

17.

Dual roles of tumour cells-derived matrix metalloproteinase 2 on brain tumour growth and invasion.

Yu CF, Chen FH, Lu MH, Hong JH, Chiang CS.

Br J Cancer. 2017 Dec 5;117(12):1828-1836. doi: 10.1038/bjc.2017.362. Epub 2017 Oct 24.

18.

Validity of cancer diagnosis in the National Health Insurance database compared with the linked National Cancer Registry in Taiwan.

Kao WH, Hong JH, See LC, Yu HP, Hsu JT, Chou IJ, Chou WC, Chiou MJ, Wang CC, Kuo CF.

Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1060-1066. doi: 10.1002/pds.4267. Epub 2017 Aug 16.

PMID:
28815803
19.

Dose-escalated radiation therapy is associated with better overall survival in patients with bone metastases from solid tumors: a propensity score-matched study.

Chou YC, Lin CY, Pai PC, Tseng CK, Hsieh CE, Chang KP, Hsu CL, Liao CT, Wang CC, Chin SC, Yen TC, Ho TY, Hong JH, Lei KF, Chang JT, Tsang NM.

Cancer Med. 2017 Sep;6(9):2087-2097. doi: 10.1002/cam4.1150. Epub 2017 Aug 15.

20.

Diffusion radiomics analysis of intratumoral heterogeneity in a murine prostate cancer model following radiotherapy: Pixelwise correlation with histology.

Lin YC, Lin G, Hong JH, Lin YP, Chen FH, Ng SH, Wang CC.

J Magn Reson Imaging. 2017 Aug;46(2):483-489. doi: 10.1002/jmri.25583. Epub 2017 Feb 8.

PMID:
28176411

Supplemental Content

Loading ...
Support Center